145 related articles for article (PubMed ID: 37566020)
1. Association of the rs8720 and rs12587
Gallegos-Arreola MP; Garibaldi-Ríos AF; Cruz-Sánchez JI; Figuera LE; Ronquillo-Carreón CA; Rosales-Reynoso MA; Gómez-Meda BC; Carrillo-Dávila IA; Puebla-Pérez AM; Montoya-Fuentes H; Peralta-Leal V; Zúñiga-González GM
Cells; 2023 Jul; 12(15):. PubMed ID: 37566020
[TBL] [Abstract][Full Text] [Related]
2.
Liu X; Yang G; Huang J; Chai L; Liu X; Dai Q; Yang Z
Biomark Med; 2020 Jan; 14(1):13-22. PubMed ID: 31729889
[No Abstract] [Full Text] [Related]
3. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
[TBL] [Abstract][Full Text] [Related]
4. KRAS polymorphisms are associated with survival of CRC in Chinese population.
Dai Q; Wei HL; Huang J; Zhou TJ; Chai L; Yang ZH
Tumour Biol; 2016 Apr; 37(4):4727-34. PubMed ID: 26515332
[TBL] [Abstract][Full Text] [Related]
5. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
6. Association of
Fu W; Zhuo Z; Hua RX; Fu K; Jia W; Zhu J; Zhang J; Cheng J; Zhou H; Xia H; He J; Liu G
Aging (Albany NY); 2019 Mar; 11(5):1551-1563. PubMed ID: 30860980
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
[TBL] [Abstract][Full Text] [Related]
8. KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.
Yang M; Xiao X; Xing X; Li X; Xia T; Long H
PLoS One; 2017; 12(3):e0174140. PubMed ID: 28328959
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
10. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
12. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
14. Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population.
Jin M; Lu F; Li X; Zhou W; Li S; Jiang Y; Wu H; Wang J
J Clin Lab Anal; 2023 Jan; 37(1):e24806. PubMed ID: 36510353
[TBL] [Abstract][Full Text] [Related]
15. One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
Myte R; Gylling B; Häggström J; Schneede J; Löfgren-Burström A; Huyghe JR; Hallmans G; Meyer K; Johansson I; Ueland PM; Palmqvist R; Van Guelpen B
PLoS One; 2018; 13(4):e0196233. PubMed ID: 29694444
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer.
Huang CJ; Teng HW; Chien CC; Lin JK; Yang SH
PLoS One; 2014; 8(6):e65117. PubMed ID: 23755178
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA‑337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
Liu X; Wang Y; Zhao J
Oncol Rep; 2017 Nov; 38(5):3187-3196. PubMed ID: 29048669
[TBL] [Abstract][Full Text] [Related]
19. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
20. Genotype GG of rs895819 Functional Polymorphism Within miR-27a Might Increase Genetic Susceptibility to Colorectal Cancer in Han Chinese Population.
Jiang Y; Lin DH; Xu JP; Chen WX; Zheng SJ; Song L
J Clin Lab Anal; 2016 Jul; 30(4):351-5. PubMed ID: 26302683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
